CardioVascular and Interventional Radiology最新文献

筛选
英文 中文
Indication and Technical Consideration for Nerve Blocks and Neurolysis for Pain Control. 神经阻滞和神经松解术用于疼痛控制的适应证和技术考虑。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-20 DOI: 10.1007/s00270-024-03934-3
Sinan Orkut, Roberto Luigi Cazzato, Julien Garnon, Guillaume Koch, Pierre Alexis Autrusseau, Pierre de Marini, Gregory Bertucci, Behnam Shaygi, Julia Weiss, Afshin Gangi
{"title":"Indication and Technical Consideration for Nerve Blocks and Neurolysis for Pain Control.","authors":"Sinan Orkut, Roberto Luigi Cazzato, Julien Garnon, Guillaume Koch, Pierre Alexis Autrusseau, Pierre de Marini, Gregory Bertucci, Behnam Shaygi, Julia Weiss, Afshin Gangi","doi":"10.1007/s00270-024-03934-3","DOIUrl":"https://doi.org/10.1007/s00270-024-03934-3","url":null,"abstract":"<p><p>Pain management in interventional radiology (IR) encompasses a variety of advanced image-guided techniques to deliver minimally invasive treatments for various pain conditions. Key procedures include nerve blocks and neurolysis, which target specific nerves to provide substantial pain relief. Effective pain management in IR relies on a thorough understanding of regional anatomy, precise technique, and careful administration of local anesthetics, neurolytic agents, and corticosteroids. Complications are minimized through strict adherence to dosage guidelines and meticulous procedural protocols. These interventions significantly improve patient outcomes, reduce recovery times, and minimize the risk of chronic pain, underscoring the pivotal role of IR in contemporary pain management. In the present review, we will report the most common nerve blocks and neurolytic interventions performed in the IR field, by focusing on anatomy, imaging guidance, major procedural points, and expected complications.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"A Global Podium to the Gold Medallist": "History of Prostatic Artery Embolization-Another Success Story of Interventional Radiology". “全球领奖台给金牌得主”:“前列腺动脉栓塞的历史——介入放射学的又一个成功故事”。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-16 DOI: 10.1007/s00270-024-03926-3
Francisco Cesar Carnevale
{"title":"\"A Global Podium to the Gold Medallist\": \"History of Prostatic Artery Embolization-Another Success Story of Interventional Radiology\".","authors":"Francisco Cesar Carnevale","doi":"10.1007/s00270-024-03926-3","DOIUrl":"https://doi.org/10.1007/s00270-024-03926-3","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein and/or Inferior Vena Cava Tumor Thrombus. 经动脉化疗栓塞联合Lenvatinib +程序性死亡-1抑制剂治疗肝静脉和/或下腔静脉肿瘤血栓的疗效和安全性
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-10 DOI: 10.1007/s00270-024-03919-2
Long-Wang Lin, Yu-Xia Nian, Xin Lin, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin, Ning Huang
{"title":"Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein and/or Inferior Vena Cava Tumor Thrombus.","authors":"Long-Wang Lin, Yu-Xia Nian, Xin Lin, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin, Ning Huang","doi":"10.1007/s00270-024-03919-2","DOIUrl":"https://doi.org/10.1007/s00270-024-03919-2","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to assess the safety and effectiveness of transarterial chemoembolization (TACE) plus lenvatinib with a programmed death-1 (PD-1) inhibitor compared with TACE plus lenvatinib and TACE alone for hepatocellular carcinoma (HCC) with the hepatic vein and/or inferior vena cava tumor thrombus (HVTT and IVCTT).</p><p><strong>Methods: </strong>Data on HCC accompanied by HVTT and IVCTT from June 2015 to August 2022 were analyzed in this single-center retrospective study. Drug-eluting bead TACE (DEB-TACE) or conventional TACE (cTACE) was used. The primary study outcomes were overall survival (OS) and progression-free survival (PFS). Univariate and multivariate Cox analyses were performed to determine the predictive factors for OS and PFS. A subgroup analysis was conducted.</p><p><strong>Results: </strong>Overall, 214 patients were enrolled. Among them, 60 received triple therapy consisting of TACE, lenvatinib, and PD-1 inhibitors (TACE + L + P), 72 received dual therapy consisting of TACE and lenvatinib (TACE + L), and 82 received TACE alone. The TACE + L + P group (16.2; 95% confidence interval [CI]: 12.8-19.5 months) had a significantly longer median OS compared with the TACE + L group (11.2; 95% CI: 10.0-12.3 months) (P = 0.001) and the TACE group (8.3; 95% CI: 7.7-8.5 months) (P < 0.001); the TACE + L + P group (12.3; 95% CI: 10.9-13.7 months) had a significantly longer median PFS compared with the TACE + L group (8.5; 95% CI: 7.7-9.2 months) (P < 0.001) and the TACE group (6.2; 95% CI: 5.8 ~ 6.3 months) (P < 0.001). Multivariate Cox analysis demonstrated that treatment strategy was a significant factor for OS and PFS. Skin rash was more common in the triple therapy group and might be attributed to PD-1 ligand inhibitor therapy (33.33% vs. 16.66%, P = 0.026).</p><p><strong>Conclusions: </strong>Triple therapy consisting of TACE plus lenvatinib with a PD-1 inhibitor showed promising efficacy for advanced HCC patients with HVTT and IVCTT, with manageable safety profiles.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provision of Interventional Radiology 3rd Edition - should we not include all stakeholders? 介入放射学第三版的规定-我们不应该包括所有利益相关者吗?
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-06 DOI: 10.1007/s00270-024-03931-6
H Bardgett, C Clarke
{"title":"Provision of Interventional Radiology 3rd Edition - should we not include all stakeholders?","authors":"H Bardgett, C Clarke","doi":"10.1007/s00270-024-03931-6","DOIUrl":"10.1007/s00270-024-03931-6","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion. 脂多多-博来霉素乳剂经动脉化疗栓塞巨大肝血管瘤的远期疗效评论。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-05 DOI: 10.1007/s00270-024-03922-7
Shahram Akhlaghpour
{"title":"Commentary on Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion.","authors":"Shahram Akhlaghpour","doi":"10.1007/s00270-024-03922-7","DOIUrl":"https://doi.org/10.1007/s00270-024-03922-7","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on Developing a Clinical Service in Interventional Radiology: Results from the 2024 CIRSE Clinical Practice Survey by Ryan et al. 关于发展介入放射学临床服务的评论:Ryan等人2024年CIRSE临床实践调查结果
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-05 DOI: 10.1007/s00270-024-03924-5
M C Burgmans
{"title":"Commentary on Developing a Clinical Service in Interventional Radiology: Results from the 2024 CIRSE Clinical Practice Survey by Ryan et al.","authors":"M C Burgmans","doi":"10.1007/s00270-024-03924-5","DOIUrl":"https://doi.org/10.1007/s00270-024-03924-5","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Personal Commentary Regarding Radial and Femoral Arterial Access. 关于桡动脉和股动脉通路的个人评论。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-01 Epub Date: 2024-11-18 DOI: 10.1007/s00270-024-03904-9
Ignacio Diaz-Lorenzo, Alberto Alonso-Burgos
{"title":"A Personal Commentary Regarding Radial and Femoral Arterial Access.","authors":"Ignacio Diaz-Lorenzo, Alberto Alonso-Burgos","doi":"10.1007/s00270-024-03904-9","DOIUrl":"10.1007/s00270-024-03904-9","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1708-1709"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipiodol ! Are Musculoskeletal Embolizations a Rebirth? Lipiodol !肌肉骨骼栓塞术是重生吗?
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-01 Epub Date: 2024-11-19 DOI: 10.1007/s00270-024-03860-4
Olivier Pellerin
{"title":"Lipiodol ! Are Musculoskeletal Embolizations a Rebirth?","authors":"Olivier Pellerin","doi":"10.1007/s00270-024-03860-4","DOIUrl":"10.1007/s00270-024-03860-4","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1774-1775"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a Clinical Service in Interventional Radiology: Results from the 2024 CIRSE Clinical Practice Survey. 发展介入放射学临床服务:2024 年 CIRSE 临床实践调查结果。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-01 Epub Date: 2024-10-09 DOI: 10.1007/s00270-024-03858-y
A G Ryan, B Slijepčević, A Cannavale, M Krokidis, J Y Chun, T de Baere, R Dezman, S Duvnjak, M A Ruffino, J Urbano, A H Mahnken
{"title":"Developing a Clinical Service in Interventional Radiology: Results from the 2024 CIRSE Clinical Practice Survey.","authors":"A G Ryan, B Slijepčević, A Cannavale, M Krokidis, J Y Chun, T de Baere, R Dezman, S Duvnjak, M A Ruffino, J Urbano, A H Mahnken","doi":"10.1007/s00270-024-03858-y","DOIUrl":"10.1007/s00270-024-03858-y","url":null,"abstract":"<p><strong>Purpose: </strong>Engaging in clinical service development is a prerequisite for Interventional Radiology (IR) to prosper as a full clinical discipline. The CIRSE Clinical Services in IR Task Force conducted a survey of CIRSE members worldwide to assess the current status of their clinical practice and to identify areas of practice requiring further support.</p><p><strong>Materials and methods: </strong>An online questionnaire with 63 structured items was sent to 7,501 CIRSE members in November 2023. The survey was closed in January 2024 and a statistical data analysis was performed.</p><p><strong>Results: </strong>A total of 520 complete responses were collected. 49.6% of respondents have an IR outpatient clinic, 34.5% have a dedicated IR day-case ward and 19.8% have dedicated inpatient beds. While 62% of respondents treat patients as the primary consultant responsible for their patients' care, 40.3% of respondents currently without their own beds have admitting rights to the hospital. Clinical practice activities are itemised in the work schedule of 41.3% of respondents and 45% routinely perform ward rounds. A total of 40% feel very positive with their personal clinical practice competency.</p><p><strong>Conclusion: </strong>With half of responding IRs having primary patient access and clinical services in place, the results are encouraging; however further engagement by those who are not yet involved is required. The authors advocate a step-wise approach towards clinical services starting with ward rounds, and subsequently taking increasing responsibility for each step in the IR patient pathway.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1795-1800"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Evidence for Endovascular Therapies in the Management of Acute Deep Vein Thrombosis. 治疗急性深静脉血栓的血管内疗法的当前证据。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-12-01 Epub Date: 2024-06-24 DOI: 10.1007/s00270-024-03784-z
Adam N Plotnik, Zachary Haber, Stephen Kee
{"title":"Current Evidence for Endovascular Therapies in the Management of Acute Deep Vein Thrombosis.","authors":"Adam N Plotnik, Zachary Haber, Stephen Kee","doi":"10.1007/s00270-024-03784-z","DOIUrl":"10.1007/s00270-024-03784-z","url":null,"abstract":"<p><p>Acute lower extremity deep vein thrombosis (DVT), specifically proximal iliofemoral DVT, is a relatively common disorder that can result in a chronic debilitating post-thrombotic syndrome (PTS), with a significant effect on a patient's quality of life. Anticoagulation is first-line therapy; however, percutaneous interventions have emerged as treatment options for patients where there is concern that anticoagulation alone will not resolve the DVT as well as prevent PTS. This paper will discuss the existing data on these interventions and review current endovascular techniques, including catheter-directed thrombolysis, pharmacomechanical thrombectomy, and large-bore mechanical thrombectomy in the management of DVT.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1571-1579"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信